关注
Hao-Ran Dai
Hao-Ran Dai
Shanghai Jiao Tong University School of Medicine
在 stu.cpu.edu.cn 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Precision caffeine therapy for apnea of prematurity and circadian rhythms: new possibilities open up
HR Dai, HL Guo, H Ya-hui, J Xu, XS Ding, R Cheng, F Chen
Frontiers in Pharmacology 13, 1053210, 2022
122022
Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio
Y Li, N Dong, YX Qin, HR Dai, YH Hu, YT Zhao, HL Guo, YY Zhang, ...
Epilepsia Open 7 (4), 737-746, 2022
122022
Integrating metabolomics and lipidomics revealed a decrease in plasma fatty acids but an increase in triglycerides in children with drug‐refractory epilepsy
HL Guo, WJ Wang, N Dong, YT Zhao, HR Dai, YH Hu, YY Zhang, J Wang, ...
Epilepsia Open 8 (2), 466-478, 2023
82023
Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms
HR Dai, Y Liu, KY Lu, X He, HL Guo, YH Hu, J Xu, XS Ding, F Chen, ...
Pharmacological Research 184, 106416, 2022
72022
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies
YT Zhao, HR Dai, Y Li, YY Zhang, HL Guo, XS Ding, YH Hu, F Chen
Frontiers in Pharmacology 13, 925018, 2022
72022
A G2/M-phase specific drug delivery system based on increased exposure of phosphatidylethanolamine on mitotic cancer cells and low pH in tumor tissues
W Hong, S Guan, Q Zhang, J Bao, H Dai, L Liu, W Li, W Kong, R Hu, ...
Journal of Drug Delivery Science and Technology 52, 224-235, 2019
62019
Therapeutic drug monitoring of caffeine and its primary metabolites in plasma using LC–ESI–MS/MS for apnea of prematurity treatment: Evaluation of ultrapure water as a …
JY Long, YH Hu, Y Xia, FF Du, HR Dai, M Tian, J Xu, R Cheng, XS Ding, ...
Biomedical Chromatography 36 (11), e5462, 2022
52022
LC-MS/MS assay for the therapeutic drug monitoring of perampanel in children with drug-resistant epilepsy
H Dai, Y Hu, J Long, Y Xia, H Guo, J Xu, X Ding, J Chen, X Lu, F Chen
Acta Chromatographica 35 (2), 149-160, 2023
42023
From “wet” matrices to “dry” blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants
HR Dai, HL Guo, WJ Wang, X Shen, R Cheng, J Xu, YH Hu, XS Ding, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 62 (1), 97-110, 2024
32024
Successful LC-MS/MS assay development and validation for determination of valproic acid and its metabolites supporting proactive pharmacovigilance
WJ Wang, YT Zhao, HR Dai, YY Zhang, J Wang, HL Guo, XS Ding, ...
Journal of Pharmaceutical and Biomedical Analysis 234, 115538, 2023
32023
Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function
DY Li, L Li, GZ Li, YH Hu, HL Guo, X Jing, F Chen, X Ji, J Xu, HR Dai
Frontiers in Pediatrics 9, 713588, 2021
22021
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants
HR Dai, HL Guo, YH Hu, Y Liu, KY Lu, YY Zhang, J Wang, XS Ding, Z Jiao, ...
Expert Opinion on Drug Metabolism & Toxicology 20 (9), 923-938, 2024
12024
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and …
CY Wang, HR Dai, YP Tan, DH Yang, XM Niu, L Han, W Wang, LL Ma, ...
Pharmaceuticals 17 (2), 238, 2024
12024
Zinc and selenium—Potential biomarkers for chronic liver disease?
Z Li, HR Dai
Alimentary Pharmacology & Therapeutics, 2024
12024
A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models
HR Dai, Y Liu, HL Guo, KY Lu, YH Hu, YY Zhang, J Wang, XS Ding, Z Jiao, ...
European Journal of Pharmaceutics and Biopharmaceutics 204, 114484, 2024
2024
Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia
ZW Shen, XY Yang, L Han, X Yang, J Xie, XQ Liu, JH Mao, HR Dai, ...
Journal of Pharmaceutical Sciences, 2024
2024
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained‐release tablets
WJ Wang, Y Li, YH Hu, J Wang, YY Zhang, L Fan, HR Dai, HL Guo, ...
CPT: Pharmacometrics & Systems Pharmacology, 2024
2024
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis
H Dai, Y Yang, C Wang, Y Chen, Y Cui, P Li, J Chen, C Yang, Z Jiao
Acta Pharmacologica Sinica, 1-14, 2024
2024
LC-MS/MS 法测定人血浆中地高辛的浓度及其在儿童患者中的应用
夏颖, 龙佳奕, 代浩然, 沈梦元, 郭宏丽, 胡雅慧, 陈峰
中国药科大学学报 52 (6), 719-724, 2021
2021
Comparative study on expectorant effects of yinma jiedu granules, feilike mixture, jubei mixture, and compound xianzhuli liquid.
Z Wang, X Zheng, L Huang, H Dai, H Zhao, Y Zhao, H Gao, X Ding
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20